clients news
Bayer’s Riociguat Meets Primary Endpoint in Pivotal Phase III Study in Patients with Pulmonary Arterial Hypertension. Bayer’s Riociguat first drug to demonstrate efficacy in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
.New data from ORIGIN Shows Lantus® use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population
.A well-established efficacy and safety record with Lantus®...
Doha, Qatar (July 19, 2012) – Renowned thought leader and experienced executive, Dr. William F. Owen, Jr., M.D., FACP, has been appointed Chief Executive Officer (CEO) of Sidra Medical and Research Center, a groundbreaking medical, research and education institution that focuses on the health and wellbeing of women and children in Doha, Qatar...
The show was presented on a site-specific installation created by Daniel Buren in collaboration with Louis Vuitton. A fundamental duality underpinned the collection: between the two colours of each grid; between shiny and matt textures; between presence and absence, in the case of the dresses with the cut-out squares...
The L’Oréal Solidarity Sourcing programme promotes social inclusion by helping economically vulnerable people find work and an income in France and countries where the Group operates.
NOT INTENDED FOR UK MEDIA New collar from Bayer Animal Health offers dogs and cats an unparalleled protection period of up to eight months from ticks and fleas...
Paris, France (May 11, 2012) – Boston Scientific Corporation (NYSE: BSX) announces extended warranties of up to 10 years, depending on the model,...
20 awards to develop nursing innovations and care solutions – Geneva, May 21, 2012 Connecting Nurses today announces award winners...
"Our Start-Up Finalists" – Press Release May 2012 Doctors 2.0™ & You (Paris May 23-24, 2012): Basil Strategies announces 11 Start-up...













